IL HB2631 | 2023-2024 | 103rd General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Failed on January 7 2025 - 100% progression
Action: 2025-01-07 - Session Sine Die
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 1-0)
Status: Failed on January 7 2025 - 100% progression
Action: 2025-01-07 - Session Sine Die
Text: Latest bill text (Introduced) [HTML]
Summary
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.
Title
MEDICAID-HEPATITIS C-TREATMENT
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2025-01-07 | House | Session Sine Die |
| 2023-05-19 | House | Rule 19(a) / Re-referred to Rules Committee |
| 2023-03-10 | House | Committee/3rd Reading Deadline Extended-Rule May 19, 2023 |
| 2023-03-09 | House | To Medicaid & Managed Care Subcommittee |
| 2023-02-28 | House | Assigned to Appropriations-Health & Human Services Committee |
| 2023-02-15 | House | Referred to Rules Committee |
| 2023-02-15 | House | First Reading |
| 2023-02-15 | House | Filed with the Clerk by Rep. Marcus C. Evans, Jr. |
Code Citations
Illinois State Sources
| Type | Source |
|---|---|
| Summary | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=2631&GAID=17&DocTypeID=HB&SessionID=112&GA=103 |
| Text | https://www.ilga.gov/legislation/103/HB/10300HB2631.htm |
